Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Henry Meds vs Ozari Health

Henry Meds
Graded #46

Higher grade

vs+8.399999999999991
Ozari Health
Graded #136

Lower grade

The verdict

Henry Meds takes it — 77.3/100 to 68.9/100.

Henry Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A flat-fee compounded pioneer — simple, but priced at the higher end of the board now.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOzari Health +3
72
75
Dose & formulationHenry Meds +16
80
64
Clinical oversightHenry Meds +1
80
79
Labs & monitoringHenry Meds +26
78
52
FulfillmentOzari Health +5
78
83
Contract termsHenry Meds +31
78
47
Henry Meds · left barOzari Health · right bar

The numbers

MetricHenry MedsOzari Health
WeighScore77.3/10068.9/100
GradeC+C
Scorecard rank#46#136
Semaglutide$249/mo$86/mo (3-mo starter plan, new patients only, compounded)
Tirzepatide$349/mo$125/mo (3-mo starter plan, new patients only, compounded)
CoverageMulti-stateAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Henry Meds

Graded #46 · C+

Strengths

  • Simple flat-fee model
  • Established brand
  • Both molecules

Where it loses points

  • Higher pricing than newer entrants
  • Compounded only
Ozari Health

Graded #136 · C

Strengths

  • Very low entry pricing — compounded semaglutide from $86/month
  • LegitScript certified and operated by a named entity (Ozari LLC)
  • Board-certified physicians; meds compounded in 503A and 503B facilities
  • Shipping included in the plan price

Where it loses points

  • The advertised rates are three-month starter plans for first-time GLP-1 users, billed $257 and $375 up front; month-to-month is $175 and $235
  • Cancelling an annual or semi-annual plan early re-prices the installments already shipped at the standard monthly rate and charges the difference
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard